Search

Search results

Current filters: Hepatitis C, Treatment, Research summary

61 search results

Eliciting accurate responses about substance use

From TreatmentUpdate 219
2017, CATIE
Research summary - Webpage

The looming arrival of Epclusa – sofosbuvir + velpatasvir

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

DAAs found highly tolerable (and effective) in people with mental health conditions

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Acid-reducing agents and HCV treatment

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Caution needed about claims of increased risk of liver cancer recurrence with use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Looking back at liver cancer rates among people who received interferon therapy

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Barcelona: Reports of unexpected cases of liver cancer in people undergoing treatment with DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Vienna doctors urge caution when assessing possible associations between liver cancer recurrence and use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Bologna researchers find no link between DAAs and liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Large review from three French studies finds no link between use of DAAs and recurrence of liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage